Showing results (161-170 of 178) with videos related to
Sort By:
Pageof 18
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 19, 2008
Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysisMasato Yoneda, Hiroki Endo, Hironori Mawatari, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 6, 2020
Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groupsHiroki Tanaka, Susumu Hijioka, Waki Hosoda, et al.Contemporary Clinical Trials Communications|July 11, 2022
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipationAtsushi Yamamoto, Takaomi Kessoku, Kosuke Tanaka, et al.DEN Open|July 2, 2026
Evaluation of Additional Treatment for Residual Cases After Endoscopic Papillectomy of Duodenal Ampullary TumorsYusuke Kurita, Keiki Nagai, Noriki Kasuga, et al.Journal of Gastroenterology|October 27, 2020
Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)Yuta Maruki, Chigusa Morizane, Yasuhito Arai, et al.Diagnostics (Basel, Switzerland)|August 10, 2024
A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care SettingAtsushi Yamamoto, Takaomi Kessoku, Tomoki Ogata, et al.Cancer Medicine|September 10, 2021
Severe anaphylaxis caused by intravenous anti-cancer drugsNobuyuki Horita, Etsuko Miyagi, Taichi Mizushima, et al.Journal of Gastroenterology and Hepatology|March 12, 2021
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver diseaseMichihiro Iwaki, Takaomi Kessoku, Anna Ozaki, et al.Neuroendocrinology|September 26, 2025
Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001)Hiroyuki Okuyama, Taro Shibuki, Naohiro Okano, et al.BMJ Open|May 31, 2022
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipationKosuke Tanaka, Takaomi Kessoku, Atsushi Yamamoto, et al.Pageof 18